Matrix metalloproteinases as therapeutic targets in breast cancer
Matrix metalloproteinases (MMPs) are the most prominent proteinases involved in tumorigenesis. They were initially recognized to promote tumor progression by remodeling the extracellular matrix through their proteolytic activity. However, accumulating evidence has revealed that some MMPs have protec...
Main Author: | Mi Jeong Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1108695/full |
Similar Items
-
Association of matrix metalloproteinase gene polymorphisms with different biological subtypes of breast cancer
by: Nadezhda V. Pavlova, et al.
Published: (2022-11-01) -
Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets
by: Kang Fu, et al.
Published: (2022-10-01) -
Role of Matrix Metalloproteinases and Their Inhibitors in Locally Invasive Papillary Thyroid Cancer
by: Irena Ivković, et al.
Published: (2022-12-01) -
Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis
by: Yusha Wang, et al.
Published: (2024-08-01) -
Matrix metalloproteinase-7 and matrix metalloproteinase-9 expression is upregulated in congenital lung malformations
by: Ayşe Parlak, et al.
Published: (2025-02-01)